Research

Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Going into science: Women scientists at Boston Children's offer advice to girls

We gathered women scientists from across Boston Children’s Hospital and asked them to advise girls wanting to enter the field. Hear what they had to say, and go in depth here for more wise words and a taste of what they’re investigating.

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 4/21/2021 4:00:01 PM
.@BostonChildrens research discovers how the preterm infant microbiome develops, providing new clues to prevent dis… https://t.co/apJCw7wjmN
BCH Innovation News @BCH_Innovation 4/20/2021 9:00:01 PM
“Understanding how the #microbiome forms in preterm #infants is essential to understanding how to intervene and inf… https://t.co/5HTvsIU0Mr
BCH Innovation News @BCH_Innovation 4/20/2021 2:43:31 PM
RT @DFBC_PedCare: Jennifer S. Whangbo, MD, PhD, will both moderate and present during today's 12:15 p.m. CT #ASPHO2021 session, "Unique Con…
BCH Innovation News @BCH_Innovation 4/19/2021 1:00:01 PM
For unclear reasons, #Shwachman Diamond, a rare bone marrow failure syndrome, can lead to deadly leukemias. Sequenc… https://t.co/mJAtautylS
BCH Innovation News @BCH_Innovation 4/18/2021 2:00:01 PM
Mutations in #TP53 and #EIF6, acquired over time, respectively contribute to and prevent #leukemia in patients with… https://t.co/Wuu1DVXs9W
BCH Innovation News @BCH_Innovation 4/17/2021 3:00:02 PM
Exciting findings for #SDS and other #cancerpredisposition syndromes: “We revealed some of the processes by which… https://t.co/h4I2a9HnlG
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer